Redeye: Alzecure Q2 - Presented new data
Redeye returns with an update following Alzecure's Q2 report and recent activities in the company. We largely reiterate our fundamental view but make some adjustments following the outcome of Alzecure's rights issue.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/